Evidence mapPaperPMID 33069326Full record

ArticleLancet (London, England)2020

Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

GBD 2019 Diseases and Injuries Collaborators

Erratum issued 30 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 30 registered trials, which are not on this map. Cited by 9,791 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9,791citing papers in PubMed, 7 pooled it
853.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06000462 phase4active not recruitingstarted 2024, after this paper: background citation

The Effect of Sodium Glucose Co-transporter 2 Inhibitor (dapagliflozin) on Weight Loss in Non-diabetic Adults with Obesity: Triple-blinded, Randomized, Placebo-controlled Trial.

Ran2024Enrolled150Registered outcomes4Posted comparisons0ConditionsDapagliflozin Adverse Reaction, Effect of Drug, Obesity, Weight LossArmsDapagliflozin 10mg Tab, Metformin 1000 mg (ttd), Placebo
Open the trial in the graph
NCT05218330 unknown statusnot on this mapstarted 2022, after this paper: background citation

Weekend Headaches in School-age Children

TypeobservationalSponsorBnai Zion Medical CenterRan2022 to 2023Enrolled100ConditionsHeadache, Child, Only
NCT05284162 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Effects of a Theory-guided Health Coaching Programme on Health Promoting Behaviours in Middle-Aged Adults With Cardiometabolic Risk: a Randomised Controlled Trial

TypeinterventionalSponsorChinese University of Hong KongRan2021 to 2023Enrolled202ConditionsCoaching, Cardiovascular Diseases, Metabolic DiseasesArmsHealth coaching
NCT05292586 phase3completednot on this mapstarted 2022, after this paper: background citation

A 12 Week, Randomized, Double-blind, Multicenter, Active Controlled, 2-Arm Parallel Group Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose (Fixed Combination of Extrafine Beclomethasone Dipropionate Plus Formoterol Fumarate) Compared to CHF 718 pMDI 800µg Total Daily Dose (Extrafine Beclomethasone Dipropionate) in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid

TypeinterventionalSponsorChiesi Farmaceutici S.p.A.Ran2022 to 2024Enrolled1,377ConditionsAsthmaArmsBeclomethasone Dipropionate/Formoterol Fumarate, Beclomethasone Dipropionate
NCT05626543 nacompletednot on this mapstarted 2022, after this paper: background citation

The Effect of Mindfulness-based Cognitive Behavior Therapy on Occupational Stress Management Among Community Secondary School Teachers in Kathmandu

TypeinterventionalSponsorTampere UniversityRan2022 to 2023Enrolled218ConditionsOccupational StressArmsCognitive behavior therapy (CBT) and Mindfulness-based stress reduction (MBSR) programs
NCT05663632 unknown statusnot on this mapstarted 2022, after this paper: background citation

Triglyceride-Glucose Index In Heart Failure Patients In Sohag University Hospital

TypeobservationalSponsorSohag UniversityRan2022 to 2023Enrolled200ConditionsHeart Failure, Insulin Resistance
NCT05704335 unknown statusnot on this mapstarted 2022, after this paper: background citation

INFLUENCEF STUDY: Epidemiology, Risk Factors and Clinical Phenotype of Headache Associated With Influenza Infection

TypeobservationalSponsorHospital Clínico Universitario de ValladolidRan2022 to 2024Enrolled100ConditionsHeadache Disorders, Influenza -Like Illness, Head Pain, MigraineArmsQuestionnaire administration
NCT05950451 completednot on this mapstarted 2023, after this paper: background citation

Self-management Education in Multi-professional Health Centres

TypeobservationalSponsorRennes University HospitalRan2023 to 2026Enrolled33ConditionsSelf-managementArmsNo intervention
NCT06008912 nacompletednot on this mapstarted 2023, after this paper: background citation

Investigation of the Effect of Calisthenic Exercise Training Combined With Aerobic Exercise on Exercise Tolerance, Physical Fitness and Plasma Lipid Profile in Patients With Dyslipidemia

TypeinterventionalSponsorÇankırı Karatekin UniversityRan2023 to 2024Enrolled39ConditionsDyslipidemiasArmsCalisthenic Exercises, Aerobic Exercises
NCT06159803 unknown statusnot on this mapstarted 2024, after this paper: background citation

LIving BEtteR With asThma - Intervention Development Study

TypeobservationalSponsorUniversity Hospital Southampton NHS Foundation TrustRan2024 to 2025Enrolled50ConditionsAsthmaArmsQualitative Interview
NCT06258473 phase1recruitingnot on this mapstarted 2024, after this paper: background citation

Addressing Gaps in the Hypertension and Diabetes Care Continuum in Rural Bangladesh Through mHealth and Decentralized Primary Care: The Dinajpur Study

TypeinterventionalSponsorBRAC UniversityRan2024 to 2026Enrolled6,750ConditionsHypertension, DiabetesArmsMulticomponent decentralized care, mHealth
NCT06267664 unknown statusnot on this mapstarted 2023, after this paper: background citation

Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP): an International Prospective Multicentric Cohort Study

Typeobservational_patient_registrySponsorHospital Clínico Universitario de ValladolidRan2023 to 2024Enrolled1,500ConditionsMigraine, Migraine Disorders, Migraine With Aura, Headache DisordersArmsPatients with migraine treated with triptans, Lasmiditan or Gepants
NCT06286007 unknown statusnot on this mapstarted 2023, after this paper: background citation

Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control

Typeobservational_patient_registrySponsorHospital Clinico Universitario de SantiagoRan2023 to 2026Enrolled784ConditionsAsthma, Pertussis, RSV InfectionArmsPCR
NCT06433349 recruitingnot on this mapstarted 2024, after this paper: background citation

A Multi-center Investigation of Family Health, Needs, Perceived Support, Self-efficacy and Quality of Life During the Cancer Trajectory: A Longitudinal Mixed Methods Study Among Danish Cancer Patients and Their Caregivers

TypeobservationalSponsorOdense University HospitalRan2024 to 2028Enrolled240ConditionsBreast Cancer, Prostate Cancer, Colorectal Cancer, Hematologic NeoplasmsArmsSurvey and interviews
NCT06513026 narecruitingnot on this mapstarted 2026, after this paper: background citation

Milk for Diabetes Prevention

TypeinterventionalSponsorAlbert Einstein College of MedicineRan2026 to 2028Enrolled40ConditionsLactose Intolerance, Lactose Intolerant, Lactase Persistence, Pre-DiabetesArmsLactose-Containing Milk, Lactose-Free Milk
NCT06514599 completednot on this mapstarted 2023, after this paper: background citation

Comparison of The Efficacy of CRP, Procalcitonin and Pro-BNP as Diagnostic and Prognostic Markers in AECOPD

Typeobservational_patient_registrySponsorKanuni Sultan Suleyman Training and Research HospitalRan2023 to 2024Enrolled196ConditionsCOPD Exacerbation Acute
NCT06522893 nacompletednot on this mapstarted 2025, after this paper: background citation

Comparison of Electrical Dry Needling and Therapeutic Exercise Versus Therapeutic Exercise in Patients With Nonspecific Chronic Neck Pain: A Randomized Clinical Trial

TypeinterventionalSponsorUniversidad de AlmeriaRan2025 to 2026Enrolled90ConditionsNeck Pain, Chronic PainArmsElectrical Dry Needling and Therapeutic exercise, Therapeutic exercise
NCT06566898 recruitingnot on this mapstarted 2024, after this paper: background citation

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients: a Genomic Epidemiology Study

TypeobservationalSponsorShanghai General Hospital, ChinaRan2024 to 2026Enrolled800ConditionsPneumonia, Next-generation Sequencing, Microbiome, Antimicrobial Resistance
NCT06695949 nacompletednot on this mapstarted 2025, after this paper: background citation

Comparison of Percutaneous Neuromodulation and Therapeutic Exercise in Patients With Nonspecific Chronic Neck Pain: A Randomized Clinical Trial

TypeinterventionalSponsorUniversidad de AlmeriaRan2025 to 2025Enrolled100ConditionsNeck Pain, Chronic PainArmsPercutaneous neuromodulation., Therapeutic Exercise.
NCT06788977 recruitingnot on this mapstarted 2024, after this paper: background citation

CEFALY Pregnancy Registry

Typeobservational_patient_registrySponsorCefaly TechnologyRan2024 to 2030Enrolled550ConditionsPregnancy, Migraine, Headache, PostpartumArmsexternal Trigeminal Nerve Stimulation
NCT06812299 completednot on this mapstarted 2023, after this paper: background citation

Migraine and Work-disability: How Treatment with Monoclonal Antibodies Against CGRP Pathway Could Reduce Work-related Burden Among Migraine Population.

Typeobservational_patient_registrySponsorIRCCS National Neurological Institute "C. Mondino" FoundationRan2023 to 2024Enrolled175ConditionsHeadache (Migraine)
NCT06819839 nacompletednot on this mapstarted 2024, after this paper: background citation

Impact of a Community Health Worker Care Model to Reduce Cardiovascular Disease Risk Among Conflict-affected Populations in Eastern Myanmar: a Cluster Randomized Controlled Trial (cRCT)

TypeinterventionalSponsorCommunity Partners InternationalRan2024 to 2025Enrolled213ConditionsCardiovascular Diseases, Hypertension, DiabetesArmsVillage Health Worker (VHW) Care Model
NCT06887231 narecruitingnot on this mapstarted 2025, after this paper: background citation

Virtual Reality (VR) Platform and Transcutaneous Electrical Nerve Stimulation (TENS) for Early Stroke Rehabilitation

TypeinterventionalSponsorMedical University of ViennaRan2025 to 2027Enrolled35ConditionsStrokeArmsVR+TENS, Conventional rehabilitation
NCT07125664 phase2not yet recruitingnot on this mapstarted 2025, after this paper: background citation

A Two-center, Randomized, Double-blind, Placebo-controlled Study of Intravenous Plasma-purified Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study)

TypeinterventionalSponsorFondazione IRCCS Policlinico San Matteo di PaviaRan2025 to 2027Enrolled36ConditionsAcute Exacerbation Chronic Obstructive Pulmonary DiseaseArmsalpha1-proteinase inhibitor, produced from the plasma of human donors (Prolastin 1000 mg, powder and solvent for solution for infusion), Placebo
NCT07298616 nacompletednot on this mapstarted 2025, after this paper: background citation

Effect of Hydrodissection Tunneling Technique on Recurrent Laryngeal Nerve Protection During Thyroidectomy: A Multicenter, Randomized Clinical Trial

TypeinterventionalSponsorWest China HospitalRan2025 to 2026Enrolled238ConditionsPatients Undergoing Open Thyroid SurgeryArmsHydrodissection tunneling technique
NCT07461415 narecruitingnot on this mapstarted 2026, after this paper: background citation

CONNECT-HTN Trial - Coaching and Navigation by CHWs Through Telehealth for High-risk Hypertension

TypeinterventionalSponsorWeill Medical College of Cornell UniversityRan2026 to 2029Enrolled3,620ConditionsHypertensionArmsCONNECT-HTN, Standard ED management
NCT07555743 phase4not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder (MDD) and Insomnia: Double-blind, Randomized, Controlled Trial

TypeinterventionalSponsorInstitut d'Investigació Biomèdica de BellvitgeRan2026 to 2028Enrolled134ConditionsInsomnia, Major Depressive DisorderArmsDaridorexant 50 mg, Placebo
NCT07602023 recruitingnot on this mapstarted 2024, after this paper: background citation

Triglyceride-rich LIPoproteins and INflammatory Cytokines After Oral FAT Loading as Potential Early Biomarkers of the Risk of Progression Towards DIABETES and Development of Complications. LIPINFAT Diabetes Study.

TypeobservationalSponsorAngelina PassaroRan2024 to 2028Enrolled150ConditionsPrediabetes / Type 2 DiabetesArmsOral Fat Load Test
NCT07709416 narecruitingnot on this mapstarted 2026, after this paper: background citation

Efficacy and Safety of Toludesvenlafaxine in the Treatment of Non-specific Low Back Pain

TypeinterventionalSponsorBeijing Tiantan HospitalRan2026 to 2028Enrolled132ConditionsNon-specific Low Back PainArmsActive Comparator #1, Toludesvenlafaxine
NCT07737158 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Efficacy and Safety of Venlafaxine in the Treatment of Non-specific Low Back Pain

TypeinterventionalSponsorBeijing Tiantan HospitalRan2026 to 2028Enrolled228ConditionsNon-specific Low Back Pain, Pain ManagementArmsControl Group, Venlafaxine group
3 · Its place in the literature

Who cites it

9,791 citing papers in PubMed, 7 syntheses or guidelines pooled it, 18,493 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

9,731 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 3 institutions in 2 countries.

GBD 2019 Diseases and Injuries Collaborators
Bispebjerg Hospital · DKInstitute of Clinical Research · USTechnical University of Denmark · DK

Funding

HRS Yrs29-34: Y33 SSA CoFundingU01AG009740 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jessica Faul, KENNETH M LANGA · 1990 to 2026
$555.8M
Wave IV Data CollectionP01HD031921 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HARRIS, KATHLEEN MULLAN · 1994 to 2020
$86.1M
EPIDEMIOLOGY AND BIOSTATISTICS OF AGINGT32AG000247 · NIA · JOHNS HOPKINS UNIVERSITY · PI Karen J. Bandeen-Roche · 1996 to 2026
$13.2M
University of Washington Center for Demography and Economics of Aging-OverallP30AG047845 · NIA · UNIVERSITY OF WASHINGTON · PI MURRAY, CHRISTOPHER J.L. · 2014 to 2019
$3.8M
Methodologies to Enhance Understanding of HIV-Associated Social DeterminantsR01MH110163 · NIMH · UNIVERSITY OF WASHINGTON · PI WANG, HAIDONG · 2016 to 2020
$1.9M
Costa Rican Health and Retirement SurveyR01AG031716 · NIA · UNIVERSITY OF CALIFORNIA BERKELEY · PI DOW, WILLIAM H. · 2008 to 2012
$1.6M
Morbid Obesity, Bariatric Surgery, and Kidney FunctionK23DK106515 · NIDDK · GEISINGER CLINIC · PI CHANG, ALEXANDER R · 2015 to 2019
$890k
Mapping impact and developing mitigation strategies for climate change-mental health nexus in the context of vulnerable adolescent populations in KenyaK43TW010716 · FIC · UNIVERSITY OF NAIROBI · PI KUMAR, MANASI · 2018 to 2022
$648k
Chief Scientist Office SCAF/15/02Chief Scientist Office SPHSU13Chief Scientist Office SPHSU15Chief Scientist Office SPHSU17FIC NIH HHS K43 TW010716Medical Research Council G0601022Medical Research Council G9901400Medical Research Council MC_U137686857Medical Research Council MC_UU_00022/2Medical Research Council MC_UU_12017/13Medical Research Council MC_UU_12017/15Medical Research Council MC_UU_12026/3Medical Research Council MR/M015084/1Medical Research Council MR/R00160X/1Medical Research Council MR/R024227/1Medical Research Council MR/S011676/1NIA NIH HHS HHSN271201300071CNIA NIH HHS P30 AG047845NIA NIH HHS R01 AG031716NIA NIH HHS U01 AG009740NICHD NIH HHS P01 HD031921NIDDK NIH HHS K23 DK106515NIMH NIH HHS R01 MH110163Wellcome Trust 109949/Z/15/ZWellcome Trust 205039/Z/16/ZWellcome Trust 206471/Z/17/Z
6 · The paper itself

Abstract

backgroundIn an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries.

methodsGBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution.

findingsGlobal health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990-2010 time period, with the greatest annualised rate of decline occurring in the 0-9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10-24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10-24 years were also in the top ten in the 25-49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50-74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI.

interpretationAs disability becomes an increasingly large component of disease burden and a larger component of health expenditure, greater research and development investment is needed to identify new, more effective intervention strategies. With a rapidly ageing global population, the demands on health services to deal with disabling outcomes, which increase with age, will require policy makers to anticipate these changes. The mix of universal and more geographically specific influences on health reinforces the need for regular reporting on population health in detail and by underlying cause to help decision makers to identify success stories of disease control to emulate, as well as opportunities to improve.

fundingBill & Melinda Gates Foundation.

Indexed as

Disability-Adjusted Life YearsGlobal Burden of DiseaseAdolescentAdultAgedAged, 80 and overAge DistributionCause of DeathChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMiddle Aged

Identifiers

PMID33069326
PMCPMC7567026
OpenAlexW3092849554

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

and 24 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.